Image pharmaphorum Editor Debates & Insight Sponsored Available on demand – The Creative Debate: Why creativity is... Debates & Insight Sponsored Available on demand: What does ‘the cloud’ mean for pharma? Audio Live webinar: Value demonstration for market access – the ne... Debates & Insight Sponsored Patient centricity: How does Boehringer Ingelheim UK measure... Patient centricity is a subject that is massively talked about but few can 'walk the talk'. Load more results
Debates & Insight Sponsored Patient centricity: How does Boehringer Ingelheim UK measure... Patient centricity is a subject that is massively talked about but few can 'walk the talk'.
News MSD takes a $400m bite of SciBrunch's KRAS drug MSD has signed a license agreement for a KRAS G12D inhibitor from China's SciBrunch, paying $400m upfront for the preclinical candidate.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
